E
Alzamend Neuro, Inc. ALZN
$2.22 -$0.14-5.93% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Net Income -2.70M -1.14M -985.80K -1.42M -974.40K
Total Depreciation and Amortization 27.70K 12.70K 12.70K 12.70K 12.70K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 42.90K 81.30K 81.30K 81.30K 90.60K
Change in Net Operating Assets 269.30K 356.80K -531.80K -2.08M -184.60K
Cash from Operations -2.36M -688.70K -1.42M -3.40M -1.06M
Capital Expenditure -- -210.00K 0.00 0.00 -90.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -210.00K 0.00 0.00 -90.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 841.70K 688.70K 1.17M --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 4.04M 647.50K 0.00 5.13M 1.96M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 4.04M 1.49M 688.70K 6.30M 1.96M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.67M 590.50K -734.90K 2.90M 817.90K